Stock Details
MRK.DE is MERCK Kommanditgesellschaft auf Aktien's stock. Stock exchange XETRA (Currency EUR). Average price in 50 days is 170.94€. Average daily volumn in 3 months 265.38k. Market cap 71.65B



Stock symbol : MRK.DE. Exchange : XETRA. Currency : EUR
Lastest price : 164.80€. Total volume : 524.77k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
Last Price
164.80€
Change
8.70
Volume
524.77k

Previous Close156.10
Open157.85
Day Range157.55-166.55
Bid165.65 x 6.7k
Ask165.70 x 11.2k
Volume524.77k
Average Volume265.38k
Market Cap71.65B
Beta0.56
52 Week Range153.45-231.50
Trailing P/E22.49
Foward P/E15.79
Dividend (Yield %)1.17%
Ex-Dividend Date2022-04-25



Financial Details


According to MERCK Kommanditgesellschaft auf Aktien's financial reports the company's revenue in 2021 were 19.69B an increase( +11.76%) over the years 2020 revenue that were of 17.53B. In 2021 the company's total earnings were 3.06B while total earnings in 2020 were 1.99B( +200%).


Loading ...



Organization

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers materi... al for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Market Cap:
71.65B
Revenue:
19.69B
Total Assets:
45.36B
Total Cash:
1.9B



News about "MERCK Kommanditgesellschaft auf Aktien"

merck-kommanditgesellschaft-auf-aktien-otcmktsmkgaf-short-interest-update-image

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) Short Interest Update

Source from : Defense World - 8 days ago

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF – Get Rating) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 308,300 shares, ...See details»


MERCK Kommanditgesellschaft auf Aktien (FRA:MRK) Stock Price Crosses Below Two Hundred Day Moving Average of $187.69

Source from : Defense World - 4 days ago

MERCK Kommanditgesellschaft auf Aktien (FRA:MRK – Get Rating) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €187.69 ($197.57) and ...See details»


MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Trading Down 0.5%

Source from : ETF Daily News - 6 days ago

MERCK Kommanditgesellschaft auf Aktien (ETR:MRK – Get Rating)’s stock price dropped 0.5% on Friday . The stock traded as low as €161.95 ($168.70) and last traded at €163.25 ($170.05).See details»


MERCK Kommanditgesellschaft auf Aktien (MKKGY)

Source from : Yahoo Finance - 4 years ago

As of 01:29PM EDT. Market open. German supplier of chemicals and materials used in making semiconductors, Merck KGaA, said on Tuesday it had signed a contract to open a semiconductor base in the ...See details»


MERCK Kommanditgesellschaft auf Aktien: Merck KGaA Delivers Solid Q1 Results and 2022 Outlook; Shares Slightly Overvalued

Source from : Yahoo Finance - 1 month ago

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (46% of 2021 sales) provides laboratory consumables and instruments to ...See details»


MERCK Kommanditgesellschaft auf Aktien (MRK.DE)

Source from : Yahoo Finance - 4 month ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»


MERCK Kommanditgesellschaft auf Aktien (MRKC.SG)

Source from : Yahoo Finance - 1 year ago

German supplier of chemicals and materials used in making semiconductors, Merck KGaA, said on Tuesday it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang, ...See details»


Merck KGaA ADR (MKKGY)

Source from : Investing.com - 4 month ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»


Nivea-Konzern Beiersdorf: Vertrauen erhöht Planungssicherheit

Source from : WirtschaftsWoche Online - 6 years ago

In den kommenden Wochen soll Maxingvest ähnlich wie der Persil-Konzern Henkel oder der Pharmahersteller Merck in eine Kommanditgesellschaft auf Aktien umgewandelt werden. Damit wird der Zugriff ...See details»


Merck KGaA to invest ~€440M to boost manufacturing capacity in Ireland

Source from : Seeking Alpha - 1 month ago

Merck KGaA's (OTCPK:MKGAF) (OTCPK:MKKGY) will spend ~€440M to expand its membrane and filtration manufacturing capabilities in Ireland. The German company said the investment, which is the ...See details»


Privatbanken in der Bundesrepublik: Den Großen immer ähnlicher

Source from : ZEIT - 4 years ago

So etwa, als 1966 das Bankhaus Burgardt & Bröckelschen in Dortmund in eine Kommanditgesellschaft auf Aktien mit 60prozentiger Beteiligung der Sparkassenzentrale in Münster umgegründet worden ist.See details»


von Jörg Lang, Euro am Sonntag

Source from : Finanzen - 6 days ago

Und es geht um die Umwandlung der Aktien ... sich auf Hauptversammlungsbeschlüsse zu Dividenden und Kapitalmaßnahmen. Diese Struktur haben auch die DAX-Konzerne wie Henkel und Merck - beides ...See details»


Here's How Day One Biopharmaceuticals Stock Could Keep Climbing

Source from : The Motley Fool - 10 days ago

On Monday, Day One Biopharmaceuticals revealed successful interim results of a clinical trial with pediatric brain cancer patients who received its lead candidate. Despite more than doubling in a ...See details»


DNA Microarray Market [+How To Increase Sales Strategies] | Size, Share Analysis | Statistics, Opportunities And Reports

Source from : Middle East North Africa Financial Network - 12 days ago

DNA Microarray Market 2022 Sales Revenue, Key Players Analysis, Development Status, Opportunity Assessment and Forecast by 2031 ...See details»